The APAC region is leading the global GLP-1 receptor agonist market, characterized by rapid growth driven by countries such as China, Japan, and India
Sign up for our newsletterStay ahead of development by receiving our newsletter on the latest sector knowledge.E-mail addressClearContinueI want to receive customized email newsletters from Watch Medier A/S, including information about our brands and group companies, conferences, courses, networking, competitions and digital services."n"nWith my consent, I also agree to the processing of my personal data and that information about my interaction with marketing messages (such as opening and reading) is collected using tracking pixels and similar technologies
2024;7 doi: 10.1001/jamanetworkopen.2024.13172
Highly recommend!Devin RobertsonLoad more
For instance, a patient might require an oral version of a medication that is only available as a tablet
DPP4 in diabetes